CA1327498C - Medical pump with infusion controlled by a detachable coded label - Google Patents
Medical pump with infusion controlled by a detachable coded labelInfo
- Publication number
- CA1327498C CA1327498C CA000613830A CA613830A CA1327498C CA 1327498 C CA1327498 C CA 1327498C CA 000613830 A CA000613830 A CA 000613830A CA 613830 A CA613830 A CA 613830A CA 1327498 C CA1327498 C CA 1327498C
- Authority
- CA
- Canada
- Prior art keywords
- knob
- infusion
- pumping
- microprocessor
- control means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1456—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6018—General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6036—General characteristics of the apparatus with identification means characterised by physical shape, e.g. array of activating switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/13—Infusion monitoring
Abstract
ABSTRACT OF THE DISCLOSURE
This invention relates to a microprocessor-based medical pump with a number of manual controls. The operation of this pump requires the attachment of a magnetic label to the front of the pump. This magnetic label includes a given number of strong permanent magnets in a pre-determined configuration which indicate the pharmaceutical product type and concentration to be infused.
The magnetic label also changes the visual scales around the manual controls. Hall Effect sensors read the pre-determined configuration and send the data to the microprocessor which also reads the manual controls. Using the pre-determined configuration data and the manual control data, the microprocessor determines the desired infusion parameters.
This invention relates to a microprocessor-based medical pump with a number of manual controls. The operation of this pump requires the attachment of a magnetic label to the front of the pump. This magnetic label includes a given number of strong permanent magnets in a pre-determined configuration which indicate the pharmaceutical product type and concentration to be infused.
The magnetic label also changes the visual scales around the manual controls. Hall Effect sensors read the pre-determined configuration and send the data to the microprocessor which also reads the manual controls. Using the pre-determined configuration data and the manual control data, the microprocessor determines the desired infusion parameters.
Description
FIELD OF T~B INVENTION
The present invention relates to a medical pump which has its pumping rate and pumping interval controlled by a magnetic label. This label visually alters the scales on the various manual controls, and, via the positions of magnets which are sensed by Hall Effect sensors within the pump, communicates a value to the pump which takes into account various factors relating to the desired pharmaceutical product infusion.
'j - DE~CRIPTION OF THE PRIOR ART
Medical pumps with infusion parameters controlled by manual dial settings, microprocessors, and electrical devices are well-known in the prior art. For example, U.S. Patent Nos.
3,701,345 and 4,320,757 disclose apparatus with electrical drive systems for injecting controlled amounts of fluid into a patient.
However, these references require the user to be cognizant of several variables such as the concentration of the pharmaceutical product within solution, the desired infusion rate of the pharmaceutical product, the weight of the patient, the total amount of pharmaceutical product desired to be injected into the patient either on a total or per unit of weight or mass, and even the cross-sectional area of the plunger of the ampule so as to calculate a desired velocity and total displacement of the plunger within the ampule of the syringe. Moreover, the user would have to . i .
" ~L
:'. 7~
"., :~ :
,, ~ .
:
be cognizant ~ven of the units of all of these variables so as to not make a calculative error. Any of these calculative errors could be disastrous to the patient.
References which show an injection system with a programmable means responsive to a keyboard include U.S. Patent Nos. 4,529,401; 4,624,661; 4,681,563; and 4,722,734. However, these systems still require several keystrokes on the part of medical personnel with a wide range of skill levels, some of whom may find such a computer-like device intimidating. Further, the exhaustion and hurried pace of many medical situations are not conducive to the consistently accurate programming needed for such devices~ Further, the difficulty in operating these devices is compounded when, after the infusion starts, medical personnel realize that the dose must be adjusted to accommodate the patient's metabolism, tolerance, and sensitivities with respect to the pharmaceutical product being infused.
U.S. Patent No. 4,741,732 uses a complicated programming scheme to effect generalized infusion rate profiles of a pharmaceutical product so as to maintain a constant pharmaceutical product concentration within the patient. This device may still have the deficiencies listed in the previous paragraph in that a manual entering of all of the data needed for a particular pharmaceutical product concentration, patient body weight, plunger cross-section is very error prone for exhausted or hurried medical personnel. These deficiencies are mitigated, only in part, by including an EPROM (electrically programmable read-only memory) -` 1 327498 which includes instructions and/or data in machine or object language form relating to the general characteristics of the desired time-dependent infusion rate profile. Even when using the EPROM device, this device is complicated and is directed more toward delivering complex time-dependent infusion rate profiles rather than providing a simple, "user-friendly" device with visually verifiable controls, for infusing a given dose of a pharmaceutical product to a patient.
It is therefore an object of this invention to provide an apparatus for infusing a wide variety of narcotics, muscle relaxants and vasoactive pharmaceutical products into a patient wherein the parameters relating to the infusion are programmed by the user into the device.
It is therefore a further object of this invention that the programming of these infusion parameters is simple and not intimidating.
It is therefore a further object of this invention that the programming of these infusion parameters is easy to verify visually.
It is therefore a further object of this invention that the user is able to vary the infusion rate manually after the initial programming so as to accommodate the patient's metabolism, ;
.,- . ~-. ~ .
.
- : .... .
,: , . .
. :
., .
-- 1 3274~8 tolerance, and sensitivities with respect to the pharmaceutical product being infused.
It is therefore a still further ob~ect of this invention that the apparatus be adaptable to a broad range of infusion applications.
The control device of the present invention includes three knobs which are related to infusion parameters. The first knob is set according to the desired infusion rate of the pharmaceutical product, the second knob is set according to the body weight of the patient, and the third knob is set according to a bolus, or the total amount of pharmaceutical product desired by unit weight of the patient. A microprocessor uses these variables to calculate a desired infusion flow, velocity of the plunger, total bolus volume, and bolus duration.
A fourth knob is used to set the mode of operation, such as "purge", "off", "stop/confirm", "bolus start" and "infuse". A
five-digit liquid crystal display and several light emitting diodes indicate the mode of operation and the total volume infused.
In order for this device to accommodate infusion of various pharmaceutical products of different concentrations, and ranges of infusion rates, a different magnetic label is manufactured for each pharmaceutical product configuration. These labels spell out the pharmaceutical product name and concentration.
These labels fit over the front panel of the pump control unit, around the knobs, so as to alter the visual scales of the desired infusion rate, bolus, and possibly patient weight knobs. So that ,`
. :
, ' :' ,, .
the new pharmaceutical product parameters and altered scales are properly taken into account, magnetic devices are embedded within predetermined sections of the labels. The position and polarity of these devices are related to the aforementioned parameters and scales and are sensed by Hall Effect sensors within the pump control device. A microprocessor within the control device uses the positions to which the knobs are set along with the information from the Hall Effect sensors to determine the desired infusion flow, plunger velocity, total bolus volume and bolus duration.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other objects and advantages of the invention will become apparent upon reading the following detailed description and upon referring to the drawings in which:
FIGURE 1 is a front perspective view of the pump and the magnetic label of the present invention;
FIGURE 2 is a front perspective view of the pump of the present invention, along with an attached syringe shown in phantom;
FIGURE 3 is a rear plan view showing the magnetic data devices of the magnetic label of the present invention;
FIGURE 4 is a block diagram of the microprocessor-based control system of the present invention; and FIGURE 5 is an exploded view of the pump control unit and the magnetic label system.
. .
:' , :
.'~ ' ' .
While the invention will be described in conjunction with an example embodiment, it will be understood that it is not invented to limit the invention to such embodiment. On the contrary, it is intended to cover all alternatives, modifications and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to the drawings in detail wherein like numerals indicate like elements throughout the several views, apparatus 10 is disclosed in FIGURE 1. The front plate 12 of apparatus 10 has four knobs--an infusion rate knob 14, a body weight knob 16, a bolus knob 18, and an operational mode selection knob 20.
The operational mode selection knob 20 has "Off", "Purge", "Stop/Confirm", "Infuse", and "Bolus Start" settings.
A two position switch 21 is used to select the syringe type. The preferred embodiment allows only for standard twenty or sixty cubic centimeter (cc) syringes, although those skilled in the art will realize that more positions could be allowed or that scaling factors proportional (or inversely proportional) to the plunger cross-section of the syringe could be incorporated into the information encoded into the label 30.
Additionally, the front plate 12 of apparatus 10 includes an "Infusing" light emitting diode 22, an "Attention" light , ,. . .
emitting diode 24, a "Bolusing" light emitting diode 26, and a five-digit liquid crystal display 28.
FIGURE 1 also shows the magnetic label ~0. Magnetic label 30 includes an alphanumeric listing 32 of the pharmaceutical product type and concentration in bold print. Magnetic label 30 also includes three apertures 34, 36, 38 which are outlined, respectively, by scales 40, 42, 44, for infusion rate, body weight and bolus, respectively.
Aperture 34, for the infusion rate knob 14, has scale 40 in units of milligrams of pharmaceutical product per kilogram of patient body weight (or mass) per minute. This may be replaced with milliliters of pharmaceutical product per kilogram of patient body weight per minute, milligrams of pharmaceutical product, or milliliters of pharmaceutical product. The milliliters or milligrams refers to the active pharmaceutical product contained within the solution of the syringe 11 and not to the volume or mass of solution.
Aperture 36, for the patient body weight (or mass) knob 16, as a scale 42 in units of kilograms. As will be described in more detail later, this knob 16 will be active only when the units of infusion rate and bolus are on a per unit patient weight basis.
Aperture 38, for the bolus knob 18, has a scale 44 in units of total milligrams of pharmaceutical product infused per kilogram of patient body weight. This may be replaced with milliliters of pharmaceutical product per kilogram of patient body weight, milligrams of pharmaceutical product, or milliliters of ., , ~ .
,, ~ ' ' ' pharmaceutical product. Again, the milliliters or milligrams refers to the active pharmaceutical product contained within the solution of the syringe 11 and not ta the volume or mass of solution.
The ranges of these scales 40, 42 and 44 are chosen so as to be appropriate for the pharmaceutical product type and concentration which is specified on alphanumeric listing 32.
Further, the units of these scales, particularly infusion rate and bolus (which may be given in units using milliliters or milligrams, and on a total or per patient body weight basis) are chosen in accordance with that associated with the particular pharmaceutical product and solu~ion of interest. If the units of infusion rate and bolus are given on a total basis rather than a per unit of patient body weight, then the scale 42 for body weight is labelled "Inactive".
~Similarly, for some "Infusing" modes, as opposed to 3'"Bolusing" modes, where either the body weight or bolus scales 42, 44 are unnecessary in that the pharmaceutical product is to be infused at a certain rate for an indefinite time period, these scale are changed to low infusion rate scales, while the infusion rate scale 40 is changed to a high infusion rate scale. As will be described in more detail, the user sets one of the infusion rate scales to zero, and the other to the desired high or low infusion rate.
Front plate 12, or other closely related structural elements of apparatus 10 have ferrous or similar components so that ~.
.'~
g the label 30 can magnetically attach to apparatus 10.
FIGURE 2 discloses the front of apparatus 10 at such an angle to disclose syringe 11 attached to apparatus 10 by clip 13.
Plunger driver 23 engages the plunger of syringe ll and is mechanically driven by drive mechanism 70 (see FIGURE 4) to expel the pharmaceutical product. The engagement of this pump apparatus 10 to the syringe 11 and the mechanical details of the drive ;
mechanism 70 are disclosed in commonly assigned U.S. Patent No.
4,804,368 issued on February 14, 1989. Those skilled in the art will realize that several different methods for engaging syringe 11 are possible without departing from the scope of this invention.
Magnetic label 30, in addition to having magnetic properties throughout its structure, also includes apertures 46, 48, and 50 in its rear portion into which strong Samarium Cobalt (rare earth) magnets may be inserted as shown in FIGURE 3. FIGURE
3 shows magnets 51 and 52 placed into apertures 46 and 50. The position and polarity of magnets 51 and 52 within apertures 46, 48, and 50 are elated to the pharmaceutical product concentration (as spelled out by alphanumeric listing 32), the adjustments necessary to compensate for the changes between scales listed on front plate 12 around knobs 14, 16, and 18 and the scales 40, 42, and 44 on magnetic label 30, and any other variables which those skilled in the art may realize are necessary for the proper calculation of desired infusion flow, plunger velocity, total bolus volume and bolus duration.
:
,, .
As previously described, this particular embodiment uses three possible magnet locations (that is apertures 46, 48 and 50), wherein each magnet has one of two possible polarities. Magnets of a single strength within a given tolerance are used. In order to provide a method for verifying the integrity of the label, magnets 51, 52 must be inserted into exactly two of the apertures 46, 48 and 50. Further, the apparatus 10 will not operate unless a label 30 with exactly two magnets 51, 52 are placed upon the apparatus in a position as shown in FIGURE 3.
This allows for 12 possible combinations of placement and polarity (a factor of three for choosing two out of three apertures and two factors of two, one for each polarity selection). Those skilled in the art will realize that more locations or levels of magnetic strength are possible in order to allow for more possible combinations without departing from the scope of this invention.
Those skilled in the art will also realize that a single combination of magnets will suffice for more than one combination of the aforementioned variables. For instance, all other things being equal, different concentrations of pharmaceutical products could be compensated for by different scales on the magnetic label 30 without changing the configuration of magnets 51, 52 within apertures 46, 48 and 50.
The dimensions of magnetic label 30 and the diameter and spacing of apertures 34, 36 and 38 are chosen so that magnetic label 30 can fit over front plate 12 as shown in FIGUR~ l, thereby , .
.
.
.- ' ' ' :
1 3274q8 altering the scales which are visually associated with knobs 14, 16, and 18.
Those skilled in the art will realize that other methods of communication from the label 30 to the apparatus 10 are available. These methods include:
1. Pins and Connectors Pins or connectors could be attached and coded on a PC board to which the label is attached.
The present invention relates to a medical pump which has its pumping rate and pumping interval controlled by a magnetic label. This label visually alters the scales on the various manual controls, and, via the positions of magnets which are sensed by Hall Effect sensors within the pump, communicates a value to the pump which takes into account various factors relating to the desired pharmaceutical product infusion.
'j - DE~CRIPTION OF THE PRIOR ART
Medical pumps with infusion parameters controlled by manual dial settings, microprocessors, and electrical devices are well-known in the prior art. For example, U.S. Patent Nos.
3,701,345 and 4,320,757 disclose apparatus with electrical drive systems for injecting controlled amounts of fluid into a patient.
However, these references require the user to be cognizant of several variables such as the concentration of the pharmaceutical product within solution, the desired infusion rate of the pharmaceutical product, the weight of the patient, the total amount of pharmaceutical product desired to be injected into the patient either on a total or per unit of weight or mass, and even the cross-sectional area of the plunger of the ampule so as to calculate a desired velocity and total displacement of the plunger within the ampule of the syringe. Moreover, the user would have to . i .
" ~L
:'. 7~
"., :~ :
,, ~ .
:
be cognizant ~ven of the units of all of these variables so as to not make a calculative error. Any of these calculative errors could be disastrous to the patient.
References which show an injection system with a programmable means responsive to a keyboard include U.S. Patent Nos. 4,529,401; 4,624,661; 4,681,563; and 4,722,734. However, these systems still require several keystrokes on the part of medical personnel with a wide range of skill levels, some of whom may find such a computer-like device intimidating. Further, the exhaustion and hurried pace of many medical situations are not conducive to the consistently accurate programming needed for such devices~ Further, the difficulty in operating these devices is compounded when, after the infusion starts, medical personnel realize that the dose must be adjusted to accommodate the patient's metabolism, tolerance, and sensitivities with respect to the pharmaceutical product being infused.
U.S. Patent No. 4,741,732 uses a complicated programming scheme to effect generalized infusion rate profiles of a pharmaceutical product so as to maintain a constant pharmaceutical product concentration within the patient. This device may still have the deficiencies listed in the previous paragraph in that a manual entering of all of the data needed for a particular pharmaceutical product concentration, patient body weight, plunger cross-section is very error prone for exhausted or hurried medical personnel. These deficiencies are mitigated, only in part, by including an EPROM (electrically programmable read-only memory) -` 1 327498 which includes instructions and/or data in machine or object language form relating to the general characteristics of the desired time-dependent infusion rate profile. Even when using the EPROM device, this device is complicated and is directed more toward delivering complex time-dependent infusion rate profiles rather than providing a simple, "user-friendly" device with visually verifiable controls, for infusing a given dose of a pharmaceutical product to a patient.
It is therefore an object of this invention to provide an apparatus for infusing a wide variety of narcotics, muscle relaxants and vasoactive pharmaceutical products into a patient wherein the parameters relating to the infusion are programmed by the user into the device.
It is therefore a further object of this invention that the programming of these infusion parameters is simple and not intimidating.
It is therefore a further object of this invention that the programming of these infusion parameters is easy to verify visually.
It is therefore a further object of this invention that the user is able to vary the infusion rate manually after the initial programming so as to accommodate the patient's metabolism, ;
.,- . ~-. ~ .
.
- : .... .
,: , . .
. :
., .
-- 1 3274~8 tolerance, and sensitivities with respect to the pharmaceutical product being infused.
It is therefore a still further ob~ect of this invention that the apparatus be adaptable to a broad range of infusion applications.
The control device of the present invention includes three knobs which are related to infusion parameters. The first knob is set according to the desired infusion rate of the pharmaceutical product, the second knob is set according to the body weight of the patient, and the third knob is set according to a bolus, or the total amount of pharmaceutical product desired by unit weight of the patient. A microprocessor uses these variables to calculate a desired infusion flow, velocity of the plunger, total bolus volume, and bolus duration.
A fourth knob is used to set the mode of operation, such as "purge", "off", "stop/confirm", "bolus start" and "infuse". A
five-digit liquid crystal display and several light emitting diodes indicate the mode of operation and the total volume infused.
In order for this device to accommodate infusion of various pharmaceutical products of different concentrations, and ranges of infusion rates, a different magnetic label is manufactured for each pharmaceutical product configuration. These labels spell out the pharmaceutical product name and concentration.
These labels fit over the front panel of the pump control unit, around the knobs, so as to alter the visual scales of the desired infusion rate, bolus, and possibly patient weight knobs. So that ,`
. :
, ' :' ,, .
the new pharmaceutical product parameters and altered scales are properly taken into account, magnetic devices are embedded within predetermined sections of the labels. The position and polarity of these devices are related to the aforementioned parameters and scales and are sensed by Hall Effect sensors within the pump control device. A microprocessor within the control device uses the positions to which the knobs are set along with the information from the Hall Effect sensors to determine the desired infusion flow, plunger velocity, total bolus volume and bolus duration.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other objects and advantages of the invention will become apparent upon reading the following detailed description and upon referring to the drawings in which:
FIGURE 1 is a front perspective view of the pump and the magnetic label of the present invention;
FIGURE 2 is a front perspective view of the pump of the present invention, along with an attached syringe shown in phantom;
FIGURE 3 is a rear plan view showing the magnetic data devices of the magnetic label of the present invention;
FIGURE 4 is a block diagram of the microprocessor-based control system of the present invention; and FIGURE 5 is an exploded view of the pump control unit and the magnetic label system.
. .
:' , :
.'~ ' ' .
While the invention will be described in conjunction with an example embodiment, it will be understood that it is not invented to limit the invention to such embodiment. On the contrary, it is intended to cover all alternatives, modifications and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to the drawings in detail wherein like numerals indicate like elements throughout the several views, apparatus 10 is disclosed in FIGURE 1. The front plate 12 of apparatus 10 has four knobs--an infusion rate knob 14, a body weight knob 16, a bolus knob 18, and an operational mode selection knob 20.
The operational mode selection knob 20 has "Off", "Purge", "Stop/Confirm", "Infuse", and "Bolus Start" settings.
A two position switch 21 is used to select the syringe type. The preferred embodiment allows only for standard twenty or sixty cubic centimeter (cc) syringes, although those skilled in the art will realize that more positions could be allowed or that scaling factors proportional (or inversely proportional) to the plunger cross-section of the syringe could be incorporated into the information encoded into the label 30.
Additionally, the front plate 12 of apparatus 10 includes an "Infusing" light emitting diode 22, an "Attention" light , ,. . .
emitting diode 24, a "Bolusing" light emitting diode 26, and a five-digit liquid crystal display 28.
FIGURE 1 also shows the magnetic label ~0. Magnetic label 30 includes an alphanumeric listing 32 of the pharmaceutical product type and concentration in bold print. Magnetic label 30 also includes three apertures 34, 36, 38 which are outlined, respectively, by scales 40, 42, 44, for infusion rate, body weight and bolus, respectively.
Aperture 34, for the infusion rate knob 14, has scale 40 in units of milligrams of pharmaceutical product per kilogram of patient body weight (or mass) per minute. This may be replaced with milliliters of pharmaceutical product per kilogram of patient body weight per minute, milligrams of pharmaceutical product, or milliliters of pharmaceutical product. The milliliters or milligrams refers to the active pharmaceutical product contained within the solution of the syringe 11 and not to the volume or mass of solution.
Aperture 36, for the patient body weight (or mass) knob 16, as a scale 42 in units of kilograms. As will be described in more detail later, this knob 16 will be active only when the units of infusion rate and bolus are on a per unit patient weight basis.
Aperture 38, for the bolus knob 18, has a scale 44 in units of total milligrams of pharmaceutical product infused per kilogram of patient body weight. This may be replaced with milliliters of pharmaceutical product per kilogram of patient body weight, milligrams of pharmaceutical product, or milliliters of ., , ~ .
,, ~ ' ' ' pharmaceutical product. Again, the milliliters or milligrams refers to the active pharmaceutical product contained within the solution of the syringe 11 and not ta the volume or mass of solution.
The ranges of these scales 40, 42 and 44 are chosen so as to be appropriate for the pharmaceutical product type and concentration which is specified on alphanumeric listing 32.
Further, the units of these scales, particularly infusion rate and bolus (which may be given in units using milliliters or milligrams, and on a total or per patient body weight basis) are chosen in accordance with that associated with the particular pharmaceutical product and solu~ion of interest. If the units of infusion rate and bolus are given on a total basis rather than a per unit of patient body weight, then the scale 42 for body weight is labelled "Inactive".
~Similarly, for some "Infusing" modes, as opposed to 3'"Bolusing" modes, where either the body weight or bolus scales 42, 44 are unnecessary in that the pharmaceutical product is to be infused at a certain rate for an indefinite time period, these scale are changed to low infusion rate scales, while the infusion rate scale 40 is changed to a high infusion rate scale. As will be described in more detail, the user sets one of the infusion rate scales to zero, and the other to the desired high or low infusion rate.
Front plate 12, or other closely related structural elements of apparatus 10 have ferrous or similar components so that ~.
.'~
g the label 30 can magnetically attach to apparatus 10.
FIGURE 2 discloses the front of apparatus 10 at such an angle to disclose syringe 11 attached to apparatus 10 by clip 13.
Plunger driver 23 engages the plunger of syringe ll and is mechanically driven by drive mechanism 70 (see FIGURE 4) to expel the pharmaceutical product. The engagement of this pump apparatus 10 to the syringe 11 and the mechanical details of the drive ;
mechanism 70 are disclosed in commonly assigned U.S. Patent No.
4,804,368 issued on February 14, 1989. Those skilled in the art will realize that several different methods for engaging syringe 11 are possible without departing from the scope of this invention.
Magnetic label 30, in addition to having magnetic properties throughout its structure, also includes apertures 46, 48, and 50 in its rear portion into which strong Samarium Cobalt (rare earth) magnets may be inserted as shown in FIGURE 3. FIGURE
3 shows magnets 51 and 52 placed into apertures 46 and 50. The position and polarity of magnets 51 and 52 within apertures 46, 48, and 50 are elated to the pharmaceutical product concentration (as spelled out by alphanumeric listing 32), the adjustments necessary to compensate for the changes between scales listed on front plate 12 around knobs 14, 16, and 18 and the scales 40, 42, and 44 on magnetic label 30, and any other variables which those skilled in the art may realize are necessary for the proper calculation of desired infusion flow, plunger velocity, total bolus volume and bolus duration.
:
,, .
As previously described, this particular embodiment uses three possible magnet locations (that is apertures 46, 48 and 50), wherein each magnet has one of two possible polarities. Magnets of a single strength within a given tolerance are used. In order to provide a method for verifying the integrity of the label, magnets 51, 52 must be inserted into exactly two of the apertures 46, 48 and 50. Further, the apparatus 10 will not operate unless a label 30 with exactly two magnets 51, 52 are placed upon the apparatus in a position as shown in FIGURE 3.
This allows for 12 possible combinations of placement and polarity (a factor of three for choosing two out of three apertures and two factors of two, one for each polarity selection). Those skilled in the art will realize that more locations or levels of magnetic strength are possible in order to allow for more possible combinations without departing from the scope of this invention.
Those skilled in the art will also realize that a single combination of magnets will suffice for more than one combination of the aforementioned variables. For instance, all other things being equal, different concentrations of pharmaceutical products could be compensated for by different scales on the magnetic label 30 without changing the configuration of magnets 51, 52 within apertures 46, 48 and 50.
The dimensions of magnetic label 30 and the diameter and spacing of apertures 34, 36 and 38 are chosen so that magnetic label 30 can fit over front plate 12 as shown in FIGUR~ l, thereby , .
.
.
.- ' ' ' :
1 3274q8 altering the scales which are visually associated with knobs 14, 16, and 18.
Those skilled in the art will realize that other methods of communication from the label 30 to the apparatus 10 are available. These methods include:
1. Pins and Connectors Pins or connectors could be attached and coded on a PC board to which the label is attached.
2. O~toelectronics The label could incorporate reflective or transmissive optoelectronics. For example, such a reflective system would have a reflective code on the label. A sensor and emitter combination would ; be installed in the pump and would be focused on the rear of the label thereby reading the code.
3. Microswitch and Pin Microswitches could be installed in the pump with through-holes over the switches. Activator pins attached to the label would pass through the holes and activate the switches. Many different variations of switches could be used such as membrane switches, pushbutton switches, etcetera.
4. Ca~acitive and Inductive Sensing Capacitive and inductive sensing would replace magnetic sensing.
~"' ' ,'. . ' . , . ' ' . ' . , .
~` 1 327498 FIGURE 4 discloses a block diagram of the internal electronics of apparatus 10. Hall Effect sensors 54, 55, 56, 57, 58 and 59 are positioned to be on the interior side of front plate 12 adjacent to apertures 46, 48, and 50 when magnetic label 30 is attached to the apparatus as shown in FIGURE 1. Each aperture has two sensors associated therewith--one sensor to detect a north polarity and one sensor to detect a south polarity. The Hall Effect sensors 54, 55, 56, 57, 58 and 59 have a current running through them. When the sensors are subjected to a magnetic field normal to the current density vector from magnets 51, 52 placed into apertures 46, 48, and 50, the current through the sensors 54, 55, 56, 57, 58 and 59 changes. This change in current is detected and converted into a digital signal by the sensors 54, 55, 56, 57, 58 and 59. This digital signal is transmitted to a parallel to serial converter 60, which in turn, communicates these values to microprocessor 66.
Microprocessor 66 drives the LCD and LED driver 61, which in turn drives LEDs 22, 24, 26 and LCD 28. Microprocessor 66 also drives audio driver 67 in order to generate audio signals such as "beeps".
Microprocessor 66 is responsive to power supply 62, low battery detector 63, reset control 64 and timing crystal 65 as shown in FIGURE 4.
The position of the infusion rate knob 14, the body weight knob 16, and the bolus knob 18 are communicated to microprocessor 66 via rotary switches 68, 70, 72 and the parallel to serial converter 60. The position of operational mode selection knob 20 is communicated to microprocessor 66 in that knob 20 is interposed between power supply 62 and microprocessor 66. The microprocessor 66 calculates the desired infusion as a product of the factors below:
1. The infusion rate as indicated by the position of infusion rate knob 14.
2. The patient body weight as indicated by the position of body weight knob 16.
3. A scaling factor to convert the position of the infusion rate knob 14 to the infusion rate indicated on scale 40 of the magnetic label 30.
4. A scaling factor to convert the position of the patient body weight knob 16 to the patient body weight indicated on scale 42 of the magnetic label 30.
~"' ' ,'. . ' . , . ' ' . ' . , .
~` 1 327498 FIGURE 4 discloses a block diagram of the internal electronics of apparatus 10. Hall Effect sensors 54, 55, 56, 57, 58 and 59 are positioned to be on the interior side of front plate 12 adjacent to apertures 46, 48, and 50 when magnetic label 30 is attached to the apparatus as shown in FIGURE 1. Each aperture has two sensors associated therewith--one sensor to detect a north polarity and one sensor to detect a south polarity. The Hall Effect sensors 54, 55, 56, 57, 58 and 59 have a current running through them. When the sensors are subjected to a magnetic field normal to the current density vector from magnets 51, 52 placed into apertures 46, 48, and 50, the current through the sensors 54, 55, 56, 57, 58 and 59 changes. This change in current is detected and converted into a digital signal by the sensors 54, 55, 56, 57, 58 and 59. This digital signal is transmitted to a parallel to serial converter 60, which in turn, communicates these values to microprocessor 66.
Microprocessor 66 drives the LCD and LED driver 61, which in turn drives LEDs 22, 24, 26 and LCD 28. Microprocessor 66 also drives audio driver 67 in order to generate audio signals such as "beeps".
Microprocessor 66 is responsive to power supply 62, low battery detector 63, reset control 64 and timing crystal 65 as shown in FIGURE 4.
The position of the infusion rate knob 14, the body weight knob 16, and the bolus knob 18 are communicated to microprocessor 66 via rotary switches 68, 70, 72 and the parallel to serial converter 60. The position of operational mode selection knob 20 is communicated to microprocessor 66 in that knob 20 is interposed between power supply 62 and microprocessor 66. The microprocessor 66 calculates the desired infusion as a product of the factors below:
1. The infusion rate as indicated by the position of infusion rate knob 14.
2. The patient body weight as indicated by the position of body weight knob 16.
3. A scaling factor to convert the position of the infusion rate knob 14 to the infusion rate indicated on scale 40 of the magnetic label 30.
4. A scaling factor to convert the position of the patient body weight knob 16 to the patient body weight indicated on scale 42 of the magnetic label 30.
5. The inverse of the pharmaceutical product concentration indicated by alphanumeric listing 32 on magnetic label 30.
Applications where the infusion rate is given on an absolute, rather than on a per body weight basis will eliminate factors 2 and 4 from the calculation.
Plunger velocity is calculated by dividing the infusion flow by:
Applications where the infusion rate is given on an absolute, rather than on a per body weight basis will eliminate factors 2 and 4 from the calculation.
Plunger velocity is calculated by dividing the infusion flow by:
6. The inverse of the plunger cross-section of the syringe 11.
:
.
\, When operating in the "Infusing" mode, only the plunger velocity needs to be calculated. However, when operating in the "Bolusing" mode, the following values need to be calculated. The microprocessor 66 calculates the desired pumping time as a product of the factors below:
:
.
\, When operating in the "Infusing" mode, only the plunger velocity needs to be calculated. However, when operating in the "Bolusing" mode, the following values need to be calculated. The microprocessor 66 calculates the desired pumping time as a product of the factors below:
7. The bolus as indicated by the position of the bolus knob 18.
8. The inverse of the infusion rate indicated by the position of infusion rate knob 14. This is the inverse of Factor 1.
9. A scaling factor to convert the position of the bolus knob 18 to the bolus indicated on scale 44 of the magnetic label 30.
10. A scaling factor to convert the inverse of the infusion rate indicated by the position of infusion rate knob 14 to the inverse of the infusion rate indicated on scale 40 of the magnetic label 30.
Total Bolus Volume is calculated by multiplying Infusion Flow by Bolus Duration.
Those skilled in the art will realize that these calculations may be done in different orders and that other factors may be necessary for some applications.
The microprocessor 66 receives factors 1, 2, and 7 from parallel to serial converter which in turn receives these values from the twelve position rotary switches 68, 70 and 72 associated with knobs 14, 16 and 18. The microprocessor 66 does the necessary "
.
- . -, ,~ . , ,.
inverse calculations, including that to derive factor 8 from factor1. The microprocessor 66 uses the data from the Hall Effect sensors to assemble a digital word to index into the non-volatile memory of microprocessor 66, such as read-only-memory tROM), to retrieve factors 3-5, 9, and 10 listed above. As will be described later in more detail, there are some infusion modes where the bolus or body weight scales are replaced by extended range infusion rate scales. In those modes, knob positions are interpreted differently in accordance with their changed function as indicated by the configuration of magnets 50, 51 in label 30. Those skilled in the art will easily recognize the change in interpretation of the knobs. Those skilled in the art will realize that several of these factors could be stored as factors pre-multiplied together with each other. Those skilled in the art will also realize that since products of various factors are retrieved from the non-volatile memory of microprocessor 66, that a single product is applicable to many individual configurations of the various factors.
Factor 6 is obtained by using the position of syringe type switch 21 feeding into microprocessor 66.
The microprocessor 66 then communicates the values of plunger velocity, infusion flow, total bolus volume and bolus duration to the drive mechanism 74 of the syringe 11. Further, microprocessor 66, using the position of knobs 14, 16, 18 and 20, and feedback information from the drive mechanism 74 of the syringe 11 to operate light emitting diodes 22, 24, 26, liquid crystal display 28, and audible alarm 29.
. ~ .. . .
- .
. ' ~
~ ' .
, 1 3~7 ~q8 Drive mechanism 74 includes motor 76, motor pulse width modulated driver 78, motor brake 80, primary encoder 82 and secondary encoder 84. Motor pulse width modulated driver 78 is responsive to pulses from microprocessor 66. Motor 76 is responsive to motor pulse width modulated driver 78. Motor 76 drives the plunger driver 23 which, in turn, drives syringe 11.
Motor speed is corrected as the microprocessor 66 reads the primary encoder 82 and adjusts the pulse width modulated speed control algorithm within microprocessor 66 for the proper speed. The ~ secondary encoder 84 monitors the rotation of the leadscrew (not i shown) of motor 76 and is used for safety purposes, such as primary encoder failure. Motor brake 80 is used to decrease coasting of the motor 80 and to prevent backward motion thereof.
FIGURE 5 shows a detailed exploded view of apparatus 10.
Magnetic label 30 includes a front sheet 84 glued over a flexible magnetic sheet 86, into which strong magnets 50, 51 are placed.
Rear sheet 88 is glued over the rear of the label 30. Knobs 14, 16, 18 and 20 are inserted into front plate 12 which is backed by steel foil 90 and plastic cover 92. A Hall Effect PC board 94 with Hall Effect Sensors 54-59 is sandwiched between plastic cover 92 and switch PC board 96 which contains most of the electronics including microprocessor 66. All of this fits into pump body 98.
To use this apparatus 10, a user is supplied a syringe 11 and a magnetic label 30 from a pharmaceutical manufacturer.
Magnets have been placed into apertures 46, 48 and 50 of the magnetic label 30 in a configuration which will ensure proper -~'' , .
- 1 3274q8 calculation of the pumping time and rate. The user places the syringe 11 into the drive mechanism 70 and the magnetic label 30 onto the apparatus. As previously stated, exactly two magnets must be in the label 30 and the label 30 must be placed onto the apparatus 10 for the apparatus 10 to operate. The user sets the operational mode selection knob 20 to the "Stop/Confirm" position.
LCD 28 will then display a label identification code. The user verifies that this matches the label identification code on the alphanumeric listing 32 of label 30. The user fills a 20 or 60 cc (cubic centimeter) syringe 11 with the amount of pharmaceutical product required. The user confirms that the concentration of the pharmaceutical product or infuscate matches the concentration listed on the alphanumeric listing 32 of label 30. The user attaches tubing (not shown) to the syringe 11, and attaches the syringe 11 to clip 13 and to plunger drive 23. The user uses prior art practices to attach a flow set (not shown) to the syringe 11 and to remove air from the line, etc.. The user turns the operational mode selection knob 20 to the "purge" position until fluid flow occurs. The "purge" position should not be used while the apparatus 10 is connected to the patient. The flow set (not shown) is attached to the patient's primary I.V. line (not shown).
The user then, depending upon the functions and values encoded into the label 30, enters into one of three modes:
.
.. . . .
.
1. Delivery of an infusion based on an infusion rate aiven bv body weight with the ca~ability of givina a loadinq dose or supplemental bolus dose.
~ The user sets the patient weight knob 20 and ; the infusion rate knob 14 and sets the operational mode selection knob 20 to "Infuse". The ! microprocessor 66 will choose a plunger velocity but will not limit the infusion to a given time or volume. The "Infusing" LED 22 will go on, the LCD
- 28 will incrementally display the amount of pharmaceutical product delivered. The infusion will stop when the user turns the-infusion rate knob 14 to "0", when the user turns the operation mode . . .
selection knob 20 to "Stop/Confirm", or when the syringe 11 is empty.
~ To administer a loading dose or supplemental .'A bolus, the user sets the desired dose on the Bolus ~, knob 18, and rotates the operation mode selection knob 20 to "Bolus Start". The user releases the knob 20, which is spring loaded in this position, when a short audible beep is generated by audio driver 67. The "Bolusing" Light Emitting Diode 26 will flash as an indicator of normal bolus delivery.
The liquid crystal display 28 will count upward (on a per kilogram of patient body weight basis) to show , . .
. , .
:
:
- , i , , the status of the present bolus. To terminate a bolus, the user rotates the operational mode selection knob 20 to "Stop/Confirm". Once a bolus is initiated, changes to the patient weight knob 16 or bolus knob 18 will not affect the bolus.
2. The deliverY of infusion based on hi~h and low rates independent of bodv weiqht.
In this mode, the Infusion Rate Scale 40 and Body Weight Scale 42 are replaced by a High Infusion Rate and a Low Infusion Rate Scale, respectively. The user sets one of these knobs to zero, and the other knob to the desired value, depending upon whether a high or low infusion rate is desired. The user then turns the operational mode selection knob 20 to "Infuse". The "Infusing" Light Emitting Diode 22 will flash and the Liquid Crystal Display 28 will begin incrementing to indicate the amount of pharmaceutical product delivered. To change the rate, the user rotates infusion rate knob to a new position. To stop an infusion, the user either sets both infusion rate knobs to zero, or turns the -~ operational mode selection knob 20 to "Stop/Confirm".
" - ' '' ~ . : ' '' ,~ - ,. . . . .
, - . : .
- ~ - -, : , -1 3274~8 3. The deliverY of an infusion based on high and low infusion rates aiven bY weiaht In this mode, the Infusion Rate Scale 40 and Bolus Scale 42 are replaced by a High Infusion Rate and a Low Infusion Rate Scale, respectively. The user sets one of these knobs to zero, and the other knob to the desired value, depending upon whether a high or low infusion rate is desired. The user sets the patient weight on patient weight knob 14. The user then turns the operational mode selection knob 20 to "Infuse". The "Infusing" Light Emitting Diode 22 will flash and the Liquid Crystal Display 28 will begin incrementing to indicate the amount of pharmaceutical product delivered. To change the rate, the user rotates infusion rate knob to a new position. To stop an infusion, the user either sets both infusion rate knobs to zero, or turns the operational mode selection knob 20 to "Stop/Confirm".
The apparatus 10 has the following warning indicators:
1. End of Syringe or Occlusion -- This is indicated by a pulsating audible alarm from audio driver 67 and flashing "Attention" Light Emitting Diode 24.
Liquid Crvstal Display 28 will irdicate which ' ' . ~ ~ .
. . . . .
, ~,, ;- . -1 3274q8 condition exists.
2. Low Battery -- This is indicated by a flashing "Attention" Light Emitting Diode 24 without activating audio driver 67. Liquid Crystal Display 28 will indicate this condition.
3. Internal Fault -- This is indicated by an audible alarm from audio driver 67 and all light emitting diodes 22, 24 and 26 coming on simultaneously.
4. Improper Switch Position -- If any switch or knob is left in or held in a position between actual -selections for over one-half second, the apparatus lO will alarm with three short audible beeps from audio driver 67. The apparatus 10 will continue to infuse at the previously chosen rate. Repositioning the switch to the proper location will terminate the alarm.
Thus the several aforementioned objects and advantages ,.
- are most effectively attained. Although a single preferred ,, embodiment of the invention has been disclosed and described in detail herein, it should be understood that this invention is in no sense limited thereby and its scope is to be determined by that of the appended claims.
Thus the several aforementioned objects and advantages are most effectively attained. Although a single preferred embodiment of the invention has been disclosed and described in . .
., ' :' . : ,, : , ' detail herein, it should be understood that this invention is in no sense limited thereby and its scope is to be determined by that of the appended claims.
~. ' - , .
- .. : ., . . :
.,: ' ::, ' ',: , ~ .
: :
:, .. . . . .
.
.: , . ,
Total Bolus Volume is calculated by multiplying Infusion Flow by Bolus Duration.
Those skilled in the art will realize that these calculations may be done in different orders and that other factors may be necessary for some applications.
The microprocessor 66 receives factors 1, 2, and 7 from parallel to serial converter which in turn receives these values from the twelve position rotary switches 68, 70 and 72 associated with knobs 14, 16 and 18. The microprocessor 66 does the necessary "
.
- . -, ,~ . , ,.
inverse calculations, including that to derive factor 8 from factor1. The microprocessor 66 uses the data from the Hall Effect sensors to assemble a digital word to index into the non-volatile memory of microprocessor 66, such as read-only-memory tROM), to retrieve factors 3-5, 9, and 10 listed above. As will be described later in more detail, there are some infusion modes where the bolus or body weight scales are replaced by extended range infusion rate scales. In those modes, knob positions are interpreted differently in accordance with their changed function as indicated by the configuration of magnets 50, 51 in label 30. Those skilled in the art will easily recognize the change in interpretation of the knobs. Those skilled in the art will realize that several of these factors could be stored as factors pre-multiplied together with each other. Those skilled in the art will also realize that since products of various factors are retrieved from the non-volatile memory of microprocessor 66, that a single product is applicable to many individual configurations of the various factors.
Factor 6 is obtained by using the position of syringe type switch 21 feeding into microprocessor 66.
The microprocessor 66 then communicates the values of plunger velocity, infusion flow, total bolus volume and bolus duration to the drive mechanism 74 of the syringe 11. Further, microprocessor 66, using the position of knobs 14, 16, 18 and 20, and feedback information from the drive mechanism 74 of the syringe 11 to operate light emitting diodes 22, 24, 26, liquid crystal display 28, and audible alarm 29.
. ~ .. . .
- .
. ' ~
~ ' .
, 1 3~7 ~q8 Drive mechanism 74 includes motor 76, motor pulse width modulated driver 78, motor brake 80, primary encoder 82 and secondary encoder 84. Motor pulse width modulated driver 78 is responsive to pulses from microprocessor 66. Motor 76 is responsive to motor pulse width modulated driver 78. Motor 76 drives the plunger driver 23 which, in turn, drives syringe 11.
Motor speed is corrected as the microprocessor 66 reads the primary encoder 82 and adjusts the pulse width modulated speed control algorithm within microprocessor 66 for the proper speed. The ~ secondary encoder 84 monitors the rotation of the leadscrew (not i shown) of motor 76 and is used for safety purposes, such as primary encoder failure. Motor brake 80 is used to decrease coasting of the motor 80 and to prevent backward motion thereof.
FIGURE 5 shows a detailed exploded view of apparatus 10.
Magnetic label 30 includes a front sheet 84 glued over a flexible magnetic sheet 86, into which strong magnets 50, 51 are placed.
Rear sheet 88 is glued over the rear of the label 30. Knobs 14, 16, 18 and 20 are inserted into front plate 12 which is backed by steel foil 90 and plastic cover 92. A Hall Effect PC board 94 with Hall Effect Sensors 54-59 is sandwiched between plastic cover 92 and switch PC board 96 which contains most of the electronics including microprocessor 66. All of this fits into pump body 98.
To use this apparatus 10, a user is supplied a syringe 11 and a magnetic label 30 from a pharmaceutical manufacturer.
Magnets have been placed into apertures 46, 48 and 50 of the magnetic label 30 in a configuration which will ensure proper -~'' , .
- 1 3274q8 calculation of the pumping time and rate. The user places the syringe 11 into the drive mechanism 70 and the magnetic label 30 onto the apparatus. As previously stated, exactly two magnets must be in the label 30 and the label 30 must be placed onto the apparatus 10 for the apparatus 10 to operate. The user sets the operational mode selection knob 20 to the "Stop/Confirm" position.
LCD 28 will then display a label identification code. The user verifies that this matches the label identification code on the alphanumeric listing 32 of label 30. The user fills a 20 or 60 cc (cubic centimeter) syringe 11 with the amount of pharmaceutical product required. The user confirms that the concentration of the pharmaceutical product or infuscate matches the concentration listed on the alphanumeric listing 32 of label 30. The user attaches tubing (not shown) to the syringe 11, and attaches the syringe 11 to clip 13 and to plunger drive 23. The user uses prior art practices to attach a flow set (not shown) to the syringe 11 and to remove air from the line, etc.. The user turns the operational mode selection knob 20 to the "purge" position until fluid flow occurs. The "purge" position should not be used while the apparatus 10 is connected to the patient. The flow set (not shown) is attached to the patient's primary I.V. line (not shown).
The user then, depending upon the functions and values encoded into the label 30, enters into one of three modes:
.
.. . . .
.
1. Delivery of an infusion based on an infusion rate aiven bv body weight with the ca~ability of givina a loadinq dose or supplemental bolus dose.
~ The user sets the patient weight knob 20 and ; the infusion rate knob 14 and sets the operational mode selection knob 20 to "Infuse". The ! microprocessor 66 will choose a plunger velocity but will not limit the infusion to a given time or volume. The "Infusing" LED 22 will go on, the LCD
- 28 will incrementally display the amount of pharmaceutical product delivered. The infusion will stop when the user turns the-infusion rate knob 14 to "0", when the user turns the operation mode . . .
selection knob 20 to "Stop/Confirm", or when the syringe 11 is empty.
~ To administer a loading dose or supplemental .'A bolus, the user sets the desired dose on the Bolus ~, knob 18, and rotates the operation mode selection knob 20 to "Bolus Start". The user releases the knob 20, which is spring loaded in this position, when a short audible beep is generated by audio driver 67. The "Bolusing" Light Emitting Diode 26 will flash as an indicator of normal bolus delivery.
The liquid crystal display 28 will count upward (on a per kilogram of patient body weight basis) to show , . .
. , .
:
:
- , i , , the status of the present bolus. To terminate a bolus, the user rotates the operational mode selection knob 20 to "Stop/Confirm". Once a bolus is initiated, changes to the patient weight knob 16 or bolus knob 18 will not affect the bolus.
2. The deliverY of infusion based on hi~h and low rates independent of bodv weiqht.
In this mode, the Infusion Rate Scale 40 and Body Weight Scale 42 are replaced by a High Infusion Rate and a Low Infusion Rate Scale, respectively. The user sets one of these knobs to zero, and the other knob to the desired value, depending upon whether a high or low infusion rate is desired. The user then turns the operational mode selection knob 20 to "Infuse". The "Infusing" Light Emitting Diode 22 will flash and the Liquid Crystal Display 28 will begin incrementing to indicate the amount of pharmaceutical product delivered. To change the rate, the user rotates infusion rate knob to a new position. To stop an infusion, the user either sets both infusion rate knobs to zero, or turns the -~ operational mode selection knob 20 to "Stop/Confirm".
" - ' '' ~ . : ' '' ,~ - ,. . . . .
, - . : .
- ~ - -, : , -1 3274~8 3. The deliverY of an infusion based on high and low infusion rates aiven bY weiaht In this mode, the Infusion Rate Scale 40 and Bolus Scale 42 are replaced by a High Infusion Rate and a Low Infusion Rate Scale, respectively. The user sets one of these knobs to zero, and the other knob to the desired value, depending upon whether a high or low infusion rate is desired. The user sets the patient weight on patient weight knob 14. The user then turns the operational mode selection knob 20 to "Infuse". The "Infusing" Light Emitting Diode 22 will flash and the Liquid Crystal Display 28 will begin incrementing to indicate the amount of pharmaceutical product delivered. To change the rate, the user rotates infusion rate knob to a new position. To stop an infusion, the user either sets both infusion rate knobs to zero, or turns the operational mode selection knob 20 to "Stop/Confirm".
The apparatus 10 has the following warning indicators:
1. End of Syringe or Occlusion -- This is indicated by a pulsating audible alarm from audio driver 67 and flashing "Attention" Light Emitting Diode 24.
Liquid Crvstal Display 28 will irdicate which ' ' . ~ ~ .
. . . . .
, ~,, ;- . -1 3274q8 condition exists.
2. Low Battery -- This is indicated by a flashing "Attention" Light Emitting Diode 24 without activating audio driver 67. Liquid Crystal Display 28 will indicate this condition.
3. Internal Fault -- This is indicated by an audible alarm from audio driver 67 and all light emitting diodes 22, 24 and 26 coming on simultaneously.
4. Improper Switch Position -- If any switch or knob is left in or held in a position between actual -selections for over one-half second, the apparatus lO will alarm with three short audible beeps from audio driver 67. The apparatus 10 will continue to infuse at the previously chosen rate. Repositioning the switch to the proper location will terminate the alarm.
Thus the several aforementioned objects and advantages ,.
- are most effectively attained. Although a single preferred ,, embodiment of the invention has been disclosed and described in detail herein, it should be understood that this invention is in no sense limited thereby and its scope is to be determined by that of the appended claims.
Thus the several aforementioned objects and advantages are most effectively attained. Although a single preferred embodiment of the invention has been disclosed and described in . .
., ' :' . : ,, : , ' detail herein, it should be understood that this invention is in no sense limited thereby and its scope is to be determined by that of the appended claims.
~. ' - , .
- .. : ., . . :
.,: ' ::, ' ',: , ~ .
: :
:, .. . . . .
.
.: , . ,
Claims (15)
1. An apparatus comprising:
pumping means;
means for controlling operation of said pumping means;
indicator means which includes information in a pre-arranged configuration for a selected mode of pump operation, wherein said control means senses said pre-arranged configuration when said indicator means is placed adjacent to said control means and wherein said control means controls said pumping means in accordance with said pre-arranged configuration.
pumping means;
means for controlling operation of said pumping means;
indicator means which includes information in a pre-arranged configuration for a selected mode of pump operation, wherein said control means senses said pre-arranged configuration when said indicator means is placed adjacent to said control means and wherein said control means controls said pumping means in accordance with said pre-arranged configuration.
2. The apparatus of claim 1 wherein said information is encoded by positioning of magnets.
3. The apparatus of claim 2 wherein said means for controlling said pump operation further include manual controls.
4. The apparatus of claim 3 wherein said indicator means includes visual scales for said manual controls when said indicator means is placed adjacent to said control means, wherein said visual scales in accordance with said pre-determined configuration and wherein said controlling means uses said pre-arranged configuration to alter its calculations in accordance with visual scales.
5. The apparatus of claim 4 wherein said indicator means is held in position adjacent to said control means by magnetic means.
6. The apparatus of claim 5 wherein said control means further includes Hall Effect sensors which sense said pre-arranged configuration of said permanent magnets.
7. The apparatus of claim 6 wherein said Hall Effect sensors sense the polarity of said permanent magnets in said pre-arranged configuration.
8. The apparatus of claim 7 wherein said pumping means drives a medical syringe.
9. The apparatus of claim 8 wherein said control means includes a microprocessor.
10. The apparatus of claim 8 wherein said control means allows said pumping means to operate only if a pre-determined number of said permanent magnets are in said pre-determined configuration.
11. The apparatus of claim 8 wherein said pumping means can run at a constant flow rate.
12. The apparatus of claim 8 wherein said pumping rate can run at a constant flow rate for a given period.
13. The apparatus of claim 8 further including lights for indicating the mode of operation of said apparatus.
14. The apparatus of claim 8 further including a multi-character display for indicating total flow from said pumping means.
15. The apparatus of claim 12 wherein said manual controls include a patient weight control knob, wherein said given period is determined from a setting of said patient weight control knob.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US251,563 | 1988-09-30 | ||
US07/251,563 US4943279A (en) | 1988-09-30 | 1988-09-30 | Medical pump with infusion controlled by a detachable coded label |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1327498C true CA1327498C (en) | 1994-03-08 |
Family
ID=22952501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000613830A Expired - Fee Related CA1327498C (en) | 1988-09-30 | 1989-09-28 | Medical pump with infusion controlled by a detachable coded label |
Country Status (13)
Country | Link |
---|---|
US (1) | US4943279A (en) |
EP (1) | EP0364010B1 (en) |
JP (1) | JP2812735B2 (en) |
KR (1) | KR910009394B1 (en) |
CN (1) | CN1042659A (en) |
AU (1) | AU615988B2 (en) |
CA (1) | CA1327498C (en) |
DE (1) | DE68906115T2 (en) |
ES (1) | ES2040979T3 (en) |
HK (1) | HK1002164A1 (en) |
IE (1) | IE64932B1 (en) |
MY (1) | MY103706A (en) |
NZ (1) | NZ228726A (en) |
Families Citing this family (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935099A (en) | 1992-09-09 | 1999-08-10 | Sims Deltec, Inc. | Drug pump systems and methods |
US6241704B1 (en) | 1901-11-22 | 2001-06-05 | Sims Deltec, Inc. | Drug pump systems and methods |
US5256157A (en) * | 1991-01-31 | 1993-10-26 | Baxter International Inc. | Automated infusion pump with replaceable memory cartridges |
JPH0757240B2 (en) * | 1991-08-09 | 1995-06-21 | アトム株式会社 | Infusion device |
AU658000B2 (en) * | 1991-09-11 | 1995-03-30 | University Of Melbourne, The | Method for intravenous drug infusion |
JPH06510448A (en) * | 1991-09-11 | 1994-11-24 | ザ ユニバーシティー オブ メルボルン | Intravenous drug injection method |
US5807316A (en) * | 1991-12-06 | 1998-09-15 | Teeple, Jr.; Edward | Method and apparatus for preparing and administering intravenous anesthesia infusions |
AU660826B2 (en) * | 1992-05-26 | 1995-07-06 | Baxter International Inc. | Infusion pump configuration scheme using eeproms |
US5383858B1 (en) | 1992-08-17 | 1996-10-29 | Medrad Inc | Front-loading medical injector and syringe for use therewith |
US6402718B1 (en) | 1992-08-17 | 2002-06-11 | Medrad, Inc. | Front-loading medical injector and syringe for use therewith |
DE69329774T2 (en) * | 1992-10-15 | 2001-06-21 | Gen Hospital Corp | INFUSION PUMP WITH ELECTRONICALLY LOADABLE MEDICINE LIBRARY |
US5395340A (en) * | 1993-03-15 | 1995-03-07 | Lee; Tzium-Shou | Infusion pump and a method for infusing patients using same |
GB9309151D0 (en) * | 1993-05-04 | 1993-06-16 | Zeneca Ltd | Syringes and syringe pumps |
AU7323994A (en) * | 1993-07-13 | 1995-02-13 | Sims Deltec, Inc. | Medical pump and method of programming |
US5368562A (en) * | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
US5389078A (en) * | 1993-10-06 | 1995-02-14 | Sims Deltec, Inc. | Programmable infusion pump for administering medication to patients |
EP1258262A3 (en) | 1993-10-28 | 2002-12-18 | Medrad, Inc. | Total system for contrast delivery |
US5569181A (en) * | 1993-10-28 | 1996-10-29 | Medrad, Inc. | Sterility assurance for contrast delivery system |
US5827219A (en) * | 1993-10-28 | 1998-10-27 | Medrad, Inc. | Injection system and pumping system for use therein |
EP0650738B1 (en) | 1993-10-28 | 2003-05-02 | Medrad, Inc. | Multi-patient fluid dispensing |
US5531697A (en) * | 1994-04-15 | 1996-07-02 | Sims Deltec, Inc. | Systems and methods for cassette identification for drug pumps |
CA2129284C (en) * | 1993-11-24 | 1999-03-09 | Kenneth J. Niehoff | Controlling plunger drives for fluid injection in animals |
US5609575A (en) * | 1994-04-11 | 1997-03-11 | Graseby Medical Limited | Infusion pump and method with dose-rate calculation |
DE69526613T2 (en) * | 1994-07-12 | 2002-08-29 | Medrad Inc | Information path control loop for a system that delivers medical fluids |
US5840026A (en) | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
US5533981A (en) * | 1994-10-06 | 1996-07-09 | Baxter International Inc. | Syringe infusion pump having a syringe plunger sensor |
US5620312A (en) * | 1995-03-06 | 1997-04-15 | Sabratek Corporation | Infusion pump with dual-latching mechanism |
US5628619A (en) * | 1995-03-06 | 1997-05-13 | Sabratek Corporation | Infusion pump having power-saving modes |
US5637093A (en) * | 1995-03-06 | 1997-06-10 | Sabratek Corporation | Infusion pump with selective backlight |
US5795327A (en) * | 1995-03-06 | 1998-08-18 | Sabratek Corporation | Infusion pump with historical data recording |
US5904668A (en) * | 1995-03-06 | 1999-05-18 | Sabratek Corporation | Cassette for an infusion pump |
US20030028145A1 (en) * | 1995-04-20 | 2003-02-06 | Duchon Douglas J. | Angiographic injector system with multiple processor redundancy |
US5772635A (en) * | 1995-05-15 | 1998-06-30 | Alaris Medical Systems, Inc. | Automated infusion system with dose rate calculator |
US5722956A (en) * | 1995-08-24 | 1998-03-03 | The General Hospital Corporation | Multi-dose syringe driver |
AUPN707195A0 (en) * | 1995-12-12 | 1996-01-11 | University Of Melbourne, The | Field programmable intravenous infusion system |
GB9601969D0 (en) * | 1996-01-31 | 1996-04-03 | Meldet Ltd | A system for the delivery of drugs and therapeutic agents |
BE1010264A5 (en) * | 1996-03-18 | 1998-04-07 | Struys Michel | Device for checking a intravenous injection. |
US5853386A (en) * | 1996-07-25 | 1998-12-29 | Alaris Medical Systems, Inc. | Infusion device with disposable elements |
US6468242B1 (en) | 1998-03-06 | 2002-10-22 | Baxter International Inc. | Medical apparatus with patient data recording |
US6554798B1 (en) * | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6958053B1 (en) | 1999-11-24 | 2005-10-25 | Medrad, Inc. | Injector providing drive member advancement and engagement with syringe plunger, and method of connecting a syringe to an injector |
US7645258B2 (en) | 1999-12-01 | 2010-01-12 | B. Braun Medical, Inc. | Patient medication IV delivery pump with wireless communication to a hospital information management system |
US6652489B2 (en) * | 2000-02-07 | 2003-11-25 | Medrad, Inc. | Front-loading medical injector and syringes, syringe interfaces, syringe adapters and syringe plungers for use therewith |
US6544229B1 (en) | 2000-05-01 | 2003-04-08 | Baxter International Inc | Linearly motile infusion pump |
AUPQ867900A0 (en) | 2000-07-10 | 2000-08-03 | Medrad, Inc. | Medical injector system |
EP1309366B1 (en) | 2000-08-10 | 2007-02-21 | Novo Nordisk A/S | Medication delivery device comprising a support for a cartridge |
US7500959B2 (en) * | 2000-10-05 | 2009-03-10 | Novo Nordisk A/S | Medication delivery system with improved dose accuracy |
US20020184369A1 (en) * | 2001-05-31 | 2002-12-05 | Parkinson Steven William | Appointment scheme for redistributing service access |
WO2003026558A2 (en) * | 2001-09-24 | 2003-04-03 | Scott Laboratories, Inc. | Methods and apparatuses for assuring quality and safety of drug administration and medical products and kits |
GB2380467A (en) * | 2001-10-02 | 2003-04-09 | Helen Clough | Removable, reusable drug dispenser label system |
US6985870B2 (en) * | 2002-01-11 | 2006-01-10 | Baxter International Inc. | Medication delivery system |
US20030141981A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | System and method for operating medical devices |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US8250483B2 (en) | 2002-02-28 | 2012-08-21 | Smiths Medical Asd, Inc. | Programmable medical infusion pump displaying a banner |
US8504179B2 (en) | 2002-02-28 | 2013-08-06 | Smiths Medical Asd, Inc. | Programmable medical infusion pump |
US7109974B2 (en) * | 2002-03-05 | 2006-09-19 | Matsushita Electric Industrial Co., Ltd. | Remote control system including an on-screen display (OSD) |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
US7553294B2 (en) | 2002-05-30 | 2009-06-30 | Medrad, Inc. | Syringe plunger sensing mechanism for a medical injector |
US7018361B2 (en) | 2002-06-14 | 2006-03-28 | Baxter International Inc. | Infusion pump |
US6997905B2 (en) | 2002-06-14 | 2006-02-14 | Baxter International Inc. | Dual orientation display for a medical device |
US20050267401A1 (en) * | 2004-05-25 | 2005-12-01 | Sherwood Services, Ag. | Safety interlock system for an enteral feeding pump |
NZ523300A (en) | 2002-12-20 | 2005-12-23 | Impian Technologies Ltd | Peristaltic pump head and tube holder |
US7835927B2 (en) * | 2002-12-27 | 2010-11-16 | Carefusion 303, Inc. | Medication management system |
DE602004015432D1 (en) | 2003-03-24 | 2008-09-11 | Novo Nordisk As | TRANSPARENT ELECTRONIC MARKING OF A MEDICATION CONTAINER |
US20040193325A1 (en) * | 2003-03-25 | 2004-09-30 | David Bonderud | Method and apparatus to prevent medication error in a networked infusion system |
US7419478B1 (en) | 2003-06-25 | 2008-09-02 | Medrad, Inc. | Front-loading syringe for medical injector having a flexible syringe retaining ring |
US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
US7666169B2 (en) | 2003-11-25 | 2010-02-23 | Medrad, Inc. | Syringe and syringe plungers for use with medical injectors |
US8954336B2 (en) | 2004-02-23 | 2015-02-10 | Smiths Medical Asd, Inc. | Server for medical device |
US8961461B2 (en) | 2004-05-27 | 2015-02-24 | Baxter International Inc. | Multi-state alarm system for a medical pump |
US7927313B2 (en) | 2004-05-27 | 2011-04-19 | Baxter International Inc. | Medical device configuration based on recognition of identification information |
US7507221B2 (en) * | 2004-10-13 | 2009-03-24 | Mallinckrodt Inc. | Powerhead of a power injection system |
JP2008520287A (en) * | 2004-11-16 | 2008-06-19 | メドラッド インコーポレーテッド | System and method for determining patient transfer function for drug infusion and modeling patient response |
ATE503510T1 (en) * | 2004-11-18 | 2011-04-15 | Japan Health Science Found | HEART DISEASE TREATMENT SYSTEM |
EP2902053B1 (en) | 2004-11-24 | 2017-09-06 | Bayer Healthcare LLC | Devices, systems and methods for fluid delivery |
US7993300B2 (en) * | 2005-02-21 | 2011-08-09 | Novo Nordisk As | Method for ensuring constant speed of a motor in an injection device |
WO2006120182A1 (en) | 2005-05-10 | 2006-11-16 | Novo Nordisk A/S | Injection device comprising an optical sensor |
US20070066940A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Systems and Methods for Detecting a Partition Position in an Infusion Pump |
US20070093753A1 (en) * | 2005-09-19 | 2007-04-26 | Lifescan, Inc. | Malfunction Detection Via Pressure Pulsation |
WO2007035567A2 (en) * | 2005-09-19 | 2007-03-29 | Lifescan, Inc. | Infusion pump with closed loop control and algorithm |
US8926569B2 (en) | 2006-03-15 | 2015-01-06 | Bayer Medical Care Inc. | Plunger covers and plungers for use in syringes and methods of fabricating plunger covers and plungers for use in syringes |
WO2007107562A2 (en) | 2006-03-20 | 2007-09-27 | Novo Nordisk A/S | Contact free reading of cartridge identification codes |
US7867197B2 (en) * | 2006-03-29 | 2011-01-11 | The General Hospital Corporation | Single-dose syringe driver |
EP2011223B1 (en) | 2006-04-12 | 2018-06-13 | Novo Nordisk A/S | Absolute position determination of movably mounted member in medication delivery device |
RU2431805C2 (en) | 2006-04-26 | 2011-10-20 | Ново Нордиск А/С | Method of contactless determination of medicine delivery device movable element position |
US8965707B2 (en) | 2006-08-03 | 2015-02-24 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
US8858526B2 (en) | 2006-08-03 | 2014-10-14 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
US8149131B2 (en) | 2006-08-03 | 2012-04-03 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
US8435206B2 (en) | 2006-08-03 | 2013-05-07 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
AU2007317669A1 (en) | 2006-10-16 | 2008-05-15 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from mulitple device management systems |
US7654127B2 (en) * | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
WO2008082937A2 (en) * | 2006-12-29 | 2008-07-10 | Medrad, Inc. | Modeling of pharmaceutical propagation |
EP3376504A1 (en) | 2006-12-29 | 2018-09-19 | Bayer Healthcare, LLC | Patient-based parameter generation systems for medical injection procedures |
USD942005S1 (en) | 2007-03-14 | 2022-01-25 | Bayer Healthcare Llc | Orange syringe plunger cover |
USD847985S1 (en) | 2007-03-14 | 2019-05-07 | Bayer Healthcare Llc | Syringe plunger cover |
USD1002840S1 (en) | 2007-03-14 | 2023-10-24 | Bayer Healthcare Llc | Syringe plunger |
EP2170165B1 (en) | 2007-07-17 | 2018-12-05 | Bayer Healthcare LLC | Systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
JP5142639B2 (en) * | 2007-09-05 | 2013-02-13 | オリンパスメディカルシステムズ株式会社 | Medical service support system, medical service support server |
US8105487B2 (en) | 2007-09-25 | 2012-01-31 | Fresenius Medical Care Holdings, Inc. | Manifolds for use in conducting dialysis |
US9358331B2 (en) | 2007-09-13 | 2016-06-07 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine with improved reservoir heating system |
US9199022B2 (en) | 2008-09-12 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Modular reservoir assembly for a hemodialysis and hemofiltration system |
US8597505B2 (en) * | 2007-09-13 | 2013-12-03 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine |
US8240636B2 (en) | 2009-01-12 | 2012-08-14 | Fresenius Medical Care Holdings, Inc. | Valve system |
US9308307B2 (en) | 2007-09-13 | 2016-04-12 | Fresenius Medical Care Holdings, Inc. | Manifold diaphragms |
US8083503B2 (en) | 2007-09-27 | 2011-12-27 | Curlin Medical Inc. | Peristaltic pump assembly and regulator therefor |
US8062008B2 (en) | 2007-09-27 | 2011-11-22 | Curlin Medical Inc. | Peristaltic pump and removable cassette therefor |
US7934912B2 (en) | 2007-09-27 | 2011-05-03 | Curlin Medical Inc | Peristaltic pump assembly with cassette and mounting pin arrangement |
DE102007049446A1 (en) | 2007-10-16 | 2009-04-23 | Cequr Aps | Catheter introducer |
CA3057807C (en) | 2007-11-29 | 2021-04-20 | Thomas P. Robinson | System and method for conducting hemodialysis and hemofiltration |
US9026370B2 (en) | 2007-12-18 | 2015-05-05 | Hospira, Inc. | User interface improvements for medical devices |
US8608484B2 (en) * | 2008-03-04 | 2013-12-17 | Medrad, Inc. | Dynamic anthropomorphic cardiovascular phantom |
US8133197B2 (en) | 2008-05-02 | 2012-03-13 | Smiths Medical Asd, Inc. | Display for pump |
US8315449B2 (en) | 2008-06-24 | 2012-11-20 | Medrad, Inc. | Identification of regions of interest and extraction of time value curves in imaging procedures |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
CN105148344B (en) | 2008-10-07 | 2019-06-11 | 弗雷塞尼斯医疗保健控股公司 | System and method are charged for dialysis system |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
US7896843B2 (en) * | 2008-10-15 | 2011-03-01 | Bioquiddity, Inc. | Special purpose fluid dispenser |
US8105269B2 (en) | 2008-10-24 | 2012-01-31 | Baxter International Inc. | In situ tubing measurements for infusion pumps |
WO2010062698A2 (en) | 2008-10-30 | 2010-06-03 | Xcorporeal, Inc. | Modular, portable dialysis system |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
CN102316917B (en) | 2009-02-13 | 2014-09-10 | 诺沃—诺迪斯克有限公司 | Medical device and cartridge |
US20100211002A1 (en) | 2009-02-18 | 2010-08-19 | Davis David L | Electromagnetic infusion pump with integral flow monitor |
US8197235B2 (en) | 2009-02-18 | 2012-06-12 | Davis David L | Infusion pump with integrated permanent magnet |
US8353864B2 (en) | 2009-02-18 | 2013-01-15 | Davis David L | Low cost disposable infusion pump |
US8137083B2 (en) | 2009-03-11 | 2012-03-20 | Baxter International Inc. | Infusion pump actuators, system and method for controlling medical fluid flowrate |
US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
AT508147B1 (en) * | 2009-06-18 | 2010-11-15 | Fronius Int Gmbh | ADJUSTMENT AID FOR A COMPONENT OF A WELDING MACHINE |
CN104721898B (en) | 2009-07-01 | 2018-05-18 | 弗雷塞尼斯医疗保健控股公司 | Drug delivery device and related system and method |
US8672873B2 (en) * | 2009-08-18 | 2014-03-18 | Cequr Sa | Medicine delivery device having detachable pressure sensing unit |
US8547239B2 (en) * | 2009-08-18 | 2013-10-01 | Cequr Sa | Methods for detecting failure states in a medicine delivery device |
US8771251B2 (en) * | 2009-12-17 | 2014-07-08 | Hospira, Inc. | Systems and methods for managing and delivering patient therapy through electronic drug delivery systems |
US8382447B2 (en) | 2009-12-31 | 2013-02-26 | Baxter International, Inc. | Shuttle pump with controlled geometry |
AU2011261296C1 (en) | 2010-06-04 | 2016-08-18 | Bayer Healthcare, Llc. | System and method for planning and monitoring multi-dose radiopharmaceutical usage on radiopharmaceutical injectors |
JP6025718B2 (en) | 2010-06-24 | 2016-11-16 | ベイヤー メディカル ケア インク. | A model for drug propagation and parameter generation for infusion protocols |
US8567235B2 (en) | 2010-06-29 | 2013-10-29 | Baxter International Inc. | Tube measurement technique using linear actuator and pressure sensor |
US9211378B2 (en) | 2010-10-22 | 2015-12-15 | Cequr Sa | Methods and systems for dosing a medicament |
MX356030B (en) | 2011-01-31 | 2018-05-09 | Fresenius Medical Care Holdings Inc | Preventing over-delivery of drug. |
WO2012108984A1 (en) | 2011-02-08 | 2012-08-16 | Fresenius Medical Care Holdings, Inc. | Magnetic sensors and related systems and methods |
CN106267472B (en) | 2011-07-15 | 2019-08-30 | 赛诺菲-安万特德国有限公司 | Drug delivery device with electromechanical driving mechanism |
EP2745204A4 (en) | 2011-08-19 | 2015-01-07 | Hospira Inc | Systems and methods for a graphical interface including a graphical representation of medical data |
JP5848921B2 (en) * | 2011-09-02 | 2016-01-27 | 川本電産株式会社 | Operation display for control panel |
JP2014527881A (en) | 2011-09-21 | 2014-10-23 | ベイヤー メディカル ケア インク. | Continuous multi-fluid pump device, drive and actuation system and method |
US9594875B2 (en) | 2011-10-21 | 2017-03-14 | Hospira, Inc. | Medical device update system |
WO2013090709A1 (en) | 2011-12-16 | 2013-06-20 | Hospira, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
EP2830687B1 (en) | 2012-03-30 | 2019-07-24 | ICU Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US9144646B2 (en) | 2012-04-25 | 2015-09-29 | Fresenius Medical Care Holdings, Inc. | Vial spiking devices and related assemblies and methods |
WO2013172811A1 (en) | 2012-05-14 | 2013-11-21 | Medrad, Inc. | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
EP3586891A1 (en) | 2012-07-31 | 2020-01-01 | ICU Medical, Inc. | Patient care system for critical medications |
CA2883273C (en) | 2012-08-31 | 2023-10-24 | Baxter Corporation Englewood | Medication requisition fulfillment system and method |
US9174003B2 (en) | 2012-09-28 | 2015-11-03 | Bayer Medical Care Inc. | Quick release plunger |
KR101695119B1 (en) | 2012-10-26 | 2017-01-23 | 백스터 코포레이션 잉글우드 | Improved image acquisition for medical dose preparation system |
NZ716476A (en) | 2012-10-26 | 2018-10-26 | Baxter Corp Englewood | Improved work station for medical dose preparation system |
NZ709436A (en) | 2012-11-13 | 2017-11-24 | Baxter Healthcare Sa | Infusion line management system |
US9201036B2 (en) | 2012-12-21 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Method and system of monitoring electrolyte levels and composition using capacitance or induction |
US9157786B2 (en) | 2012-12-24 | 2015-10-13 | Fresenius Medical Care Holdings, Inc. | Load suspension and weighing system for a dialysis machine reservoir |
KR102328988B1 (en) * | 2013-01-23 | 2021-11-22 | 백스터 코포레이션 잉글우드 | Patient care device-specific configuration output |
CA2896100C (en) | 2013-01-28 | 2021-04-27 | Smiths Medical Asd, Inc. | Medication safety devices and methods |
US9641432B2 (en) | 2013-03-06 | 2017-05-02 | Icu Medical, Inc. | Medical device communication method |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
US9433720B2 (en) | 2013-03-14 | 2016-09-06 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
US20140263062A1 (en) | 2013-03-14 | 2014-09-18 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
CA2913421C (en) | 2013-05-24 | 2022-02-15 | Hospira, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
EP3003442B1 (en) | 2013-05-29 | 2020-12-30 | ICU Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
CA2913915C (en) | 2013-05-29 | 2022-03-29 | Hospira, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
AU2014312122A1 (en) | 2013-08-30 | 2016-04-07 | Icu Medical, Inc. | System and method of monitoring and managing a remote infusion regimen |
US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
ES2881386T3 (en) * | 2013-09-24 | 2021-11-29 | Kpr Us Llc | Feeding set and enteral feeding pump |
US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
US9354640B2 (en) | 2013-11-11 | 2016-05-31 | Fresenius Medical Care Holdings, Inc. | Smart actuator for valve |
US10042986B2 (en) | 2013-11-19 | 2018-08-07 | Icu Medical, Inc. | Infusion pump automation system and method |
ES2776363T3 (en) | 2014-02-28 | 2020-07-30 | Icu Medical Inc | Infusion set and method using dual wavelength in-line optical air detection |
AU2015231396B2 (en) | 2014-03-19 | 2018-12-06 | Bayer Healthcare Llc | System for syringe engagement to an injector |
WO2015168427A1 (en) | 2014-04-30 | 2015-11-05 | Hospira, Inc. | Patient care system with conditional alarm forwarding |
WO2015184366A1 (en) | 2014-05-29 | 2015-12-03 | Hospira, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
JP2017525032A (en) | 2014-06-30 | 2017-08-31 | バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood | Managed medical information exchange |
US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
EP3937116A1 (en) | 2014-12-05 | 2022-01-12 | Baxter Corporation Englewood | Dose preparation data analytics |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
CA2973257C (en) | 2015-01-09 | 2023-09-19 | Bayer Healthcare Llc | Multiple fluid delivery system with multi-use disposable set and features thereof |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
JP2018507487A (en) | 2015-03-03 | 2018-03-15 | バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood | Pharmacy workflow management with alert integration |
WO2016176042A1 (en) * | 2015-04-27 | 2016-11-03 | Smiths Medical Asd, Inc. | Systems and methods for providing note-taking surfaces on infusion pumps |
EP3304370B1 (en) | 2015-05-26 | 2020-12-30 | ICU Medical, Inc. | Infusion pump system and method with multiple drug library editor source capability |
CN116206744A (en) | 2015-06-25 | 2023-06-02 | 甘布罗伦迪亚股份公司 | Medical device systems and methods with distributed databases |
US9480797B1 (en) | 2015-10-28 | 2016-11-01 | Bayer Healthcare Llc | System and method for syringe plunger engagement with an injector |
US10898638B2 (en) | 2016-03-03 | 2021-01-26 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
CN105963830A (en) * | 2016-04-20 | 2016-09-28 | 深圳市杰仕博科技有限公司 | Atomizer capable of intelligently identifying working mode |
AU2017264784B2 (en) | 2016-05-13 | 2022-04-21 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
WO2017214441A1 (en) | 2016-06-10 | 2017-12-14 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
WO2018013842A1 (en) | 2016-07-14 | 2018-01-18 | Icu Medical, Inc. | Multi-communication path selection and security system for a medical device |
CN106267509B (en) * | 2016-08-03 | 2019-07-09 | 刘芳 | A kind of air flue humidification pump |
AU2017381172A1 (en) | 2016-12-21 | 2019-06-13 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
AU2018326380B2 (en) | 2017-08-31 | 2024-02-29 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
CA3067625A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Injector pressure calibration system and method |
US11141535B2 (en) | 2017-08-31 | 2021-10-12 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
CA3068544A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
CN110809482B (en) | 2017-08-31 | 2023-03-07 | 拜耳医药保健有限公司 | Fluid injector system volume compensation system and method |
US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
HUE061426T2 (en) | 2018-02-27 | 2023-06-28 | Bayer Healthcare Llc | Syringe plunger engagement mechanism |
AU2019306490A1 (en) | 2018-07-17 | 2021-02-04 | Icu Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
US11139058B2 (en) | 2018-07-17 | 2021-10-05 | Icu Medical, Inc. | Reducing file transfer between cloud environment and infusion pumps |
US10741280B2 (en) | 2018-07-17 | 2020-08-11 | Icu Medical, Inc. | Tagging pump messages with identifiers that facilitate restructuring |
EP3824383B1 (en) | 2018-07-17 | 2023-10-11 | ICU Medical, Inc. | Systems and methods for facilitating clinical messaging in a network environment |
US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
AU2019309766A1 (en) | 2018-07-26 | 2021-03-18 | Icu Medical, Inc. | Drug library management system |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
WO2022020184A1 (en) | 2020-07-21 | 2022-01-27 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370983A (en) * | 1971-01-20 | 1983-02-01 | Lichtenstein Eric Stefan | Computer-control medical care system |
DE2608995C3 (en) * | 1976-03-04 | 1979-08-16 | Apparatebau Hundsbach Prof. Dr.-Ing. Habil., Dr.Phil.Nat. Karl Otto Lehmann, Nachf. Gmbh & Cie, 7570 Baden-Baden | Device for the presetting of liquid quantities |
US4559037A (en) * | 1977-12-28 | 1985-12-17 | Siemens Aktiengesellschaft | Device for the pre-programmable infusion of liquids |
US4275727A (en) * | 1980-01-07 | 1981-06-30 | Keeri Szanto Michael | Device for monitoring and controlling self-administered intravenous drug dosage |
JPS56124938A (en) * | 1980-03-06 | 1981-09-30 | Nec Corp | Intelligent keyboard |
US4529401A (en) * | 1982-01-11 | 1985-07-16 | Cardiac Pacemakers, Inc. | Ambulatory infusion pump having programmable parameters |
DE3202426A1 (en) * | 1982-01-26 | 1983-07-28 | Euro-Medica S.A., Luxembourg | Device for performing pressure infusions |
JPS596723U (en) * | 1982-07-05 | 1984-01-17 | カルソニックカンセイ株式会社 | Residual liquid level display device |
US4551134A (en) * | 1982-08-06 | 1985-11-05 | Nuvatec, Inc. | Intravenous set |
FR2533692A1 (en) * | 1982-09-28 | 1984-03-30 | Modular | Measuring device with set of interchangeable scales |
US4624661A (en) * | 1982-11-16 | 1986-11-25 | Surgidev Corp. | Drug dispensing system |
US4673391A (en) * | 1983-05-31 | 1987-06-16 | Koichi Sakurai | Non-contact controlled micropump |
SE451541B (en) * | 1983-06-30 | 1987-10-19 | Gambro Lundia Ab | EXTRACORPORAL BLOOD TREATMENT SYSTEM |
JPS61500589A (en) * | 1983-12-08 | 1986-04-03 | デイゼトロニツク アクチエンゲゼルシヤフト | drip device |
DE3474412D1 (en) * | 1984-04-14 | 1988-11-10 | Ferring Biotechnik | Device for the intermittent delivery of medicaments |
US4741732A (en) * | 1984-05-10 | 1988-05-03 | The University Of Melbourne | Open-loop control of drug infusion |
DE8427374U1 (en) * | 1984-09-18 | 1985-01-24 | Dr. Johannes Heidenhain Gmbh, 8225 Traunreut | keyboard |
US4565542A (en) * | 1984-10-19 | 1986-01-21 | Deltec Systems, Inc. | Locking mechanism for a drug delivery system |
EP0375673A3 (en) * | 1985-03-20 | 1990-08-01 | Knight, Robert Leonard Harry | An infusion apparatus |
JPS61164537U (en) * | 1985-03-28 | 1986-10-13 | ||
CH665955A5 (en) * | 1985-11-19 | 1988-06-30 | Universo Sa | Manually programmable injector - has interchangeable drug cartridge, and data input setting the valves which can be manually selected |
US4690673A (en) * | 1985-11-26 | 1987-09-01 | Imed Corporation | Dual mode I.V. infusion device with distal sensor |
US4648869A (en) * | 1985-12-04 | 1987-03-10 | American Hospital Supply Corporation | Automatic infiltration detection system and method |
US4714462A (en) * | 1986-02-03 | 1987-12-22 | Intermedics Infusaid, Inc. | Positive pressure programmable infusion pump |
US4741736A (en) * | 1986-12-10 | 1988-05-03 | I-Flow Corporation | Programmable infusion pump |
JPS63182995A (en) * | 1987-01-24 | 1988-07-28 | Matsushita Electric Works Ltd | Control status display system for load controller |
US4838860A (en) * | 1987-06-26 | 1989-06-13 | Pump Controller Corporation | Infusion pump |
-
1988
- 1988-09-30 US US07/251,563 patent/US4943279A/en not_active Expired - Lifetime
-
1989
- 1989-02-23 DE DE89200458T patent/DE68906115T2/en not_active Expired - Fee Related
- 1989-02-23 EP EP89200458A patent/EP0364010B1/en not_active Expired - Lifetime
- 1989-02-23 ES ES198989200458T patent/ES2040979T3/en not_active Expired - Lifetime
- 1989-03-02 AU AU30946/89A patent/AU615988B2/en not_active Ceased
- 1989-03-03 MY MYPI89000265A patent/MY103706A/en unknown
- 1989-04-13 NZ NZ228726A patent/NZ228726A/en unknown
- 1989-04-13 IE IE118089A patent/IE64932B1/en not_active IP Right Cessation
- 1989-05-31 KR KR1019890007421A patent/KR910009394B1/en not_active IP Right Cessation
- 1989-09-25 CN CN89107486A patent/CN1042659A/en active Pending
- 1989-09-28 CA CA000613830A patent/CA1327498C/en not_active Expired - Fee Related
- 1989-09-29 JP JP1255105A patent/JP2812735B2/en not_active Expired - Fee Related
-
1998
- 1998-02-13 HK HK98101140A patent/HK1002164A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0364010A2 (en) | 1990-04-18 |
US4943279A (en) | 1990-07-24 |
HK1002164A1 (en) | 1998-08-07 |
DE68906115D1 (en) | 1993-05-27 |
AU3094689A (en) | 1990-04-05 |
CN1042659A (en) | 1990-06-06 |
KR910009394B1 (en) | 1991-11-15 |
JP2812735B2 (en) | 1998-10-22 |
KR900004354A (en) | 1990-04-12 |
IE64932B1 (en) | 1995-09-20 |
ES2040979T3 (en) | 1993-11-01 |
NZ228726A (en) | 1991-11-26 |
DE68906115T2 (en) | 1993-12-02 |
EP0364010A3 (en) | 1990-04-25 |
MY103706A (en) | 1993-08-28 |
EP0364010B1 (en) | 1993-04-21 |
JPH02146281A (en) | 1990-06-05 |
AU615988B2 (en) | 1991-10-17 |
IE891180L (en) | 1990-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1327498C (en) | Medical pump with infusion controlled by a detachable coded label | |
US5078683A (en) | Programmable infusion system | |
US5176502A (en) | Syringe pump and the like for delivering medication | |
US5795327A (en) | Infusion pump with historical data recording | |
US5683367A (en) | Infusion pump with different operating modes | |
US4850972A (en) | Progammable multiple pump medication infusion system with printer | |
US5904668A (en) | Cassette for an infusion pump | |
US6468242B1 (en) | Medical apparatus with patient data recording | |
EP0497041B1 (en) | Automated infusion pump with replaceable memory cartridges | |
US5620312A (en) | Infusion pump with dual-latching mechanism | |
US5628619A (en) | Infusion pump having power-saving modes | |
US5637093A (en) | Infusion pump with selective backlight | |
EP0327209B1 (en) | Motor unit for a fluid pump | |
US7503903B2 (en) | Automated fluid flow control system | |
DK2384207T3 (en) | MEDICAL INJECTION DEVICE WITH ELECTRICAL ENGINE DRIVE CONTROL | |
EP0801578B1 (en) | Medicinal fluid pump having multiple stored protocols | |
JP3270066B2 (en) | Drug injection device with optical motion sensor | |
JP2801617B2 (en) | Fluid supply control / monitoring device for drug injection system | |
JPH02286169A (en) | Pumping device for medical purpose | |
WO2005082450A1 (en) | Automated fluid flow control system | |
JP3290263B2 (en) | Drive control method of peristaltic infusion pump | |
WO2004052429A1 (en) | A syringe driver assembly | |
JP3378054B2 (en) | Drive control method for peristaltic infusion pump | |
CA2208791C (en) | Medicinal fluid pump having multiple stored protocols | |
White | Patient-Controlled Analgesia (Part I): Historical Perspective |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |